Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics: a Multi-center Prospective Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Beijing, China
- Recruiting
- Peking University Cancer Hospital & Institute
-
Contact:
- Lei Tang
-
Fuzhou, China
- Recruiting
- Fujian Medical University Union Hospital
-
Contact:
- Changming Huang, MD
-
Guangzhou, China
- Recruiting
- Nanfang Hospital of Southern Medical University
-
Contact:
- Guoxin Li
-
Guangzhou, China
- Recruiting
- Guangdong Provincial People's Hospital
-
Contact:
- Zaiyi Liu, MD
-
Guangzhou, China
- Recruiting
- Affiliated Cancer Hospital and institute of Guangzhou Medical University
-
Contact:
- Shuzhong Cui, MD
-
Guangzhou, China
- Recruiting
- Sun Yat-sen University Cancer Hospital
-
Contact:
- Linquan Tang, MD
-
Guiyang, China
- Recruiting
- Guizhou Provincial People's Hospital
-
Contact:
- Rongping Wang
-
Kunming, China
- Recruiting
- Yunnan Cancer Hospital
-
Contact:
- Zhenhui Li, MD
-
Taiyuan, China
- Recruiting
- Shanxi Province Cancer Hospital
-
Contact:
- Yanfen Cui, MD
-
Zhengzhou, China
- Recruiting
- Henan Cancer Hospital
-
Contact:
- Jing Li
-
Zhengzhou, China
- Recruiting
- The First Affiliated Hospital of Zhengzhou University
-
Contact:
- Jianbo Gao
-
Zhenjiang, China
- Recruiting
- Zhenjiang First People's Hospital
-
Contact:
- Xiuhong Shan
-
-
-
-
-
Milan, Italy
- Recruiting
- Scientific Institute San Raffaele
-
Contact:
- Francesco De Cobelli
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- (1) diagnosed advanced gastric cancer (≥cT3) by endoscopy-biopsy pathology, combined with CT and/or endoscopic ultrasound;
- (2) with both enhanced CT and laparoscopy;
- (3) without typical peritoneal metastasis indications in CT (diffuse omental nodules or omental cake, large amount of ascites, obvious irregular thickening with high peritoneal enhancement);
- (4) without other evidence of distant metastasis, and no stage IV features on CT.
Exclusion Criteria:
- (1) previous abdominal surgery;
- (2) previous abdominal malignancies or inflammatory diseases;
- (3) time intervals between CT and laparoscopy longer than 2 weeks;
- (4) CT image artifacts that undermine peritoneal lesion assessment.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Zhenjiang First People's Hospital
Zhenjiang First People's Hospital collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
The First Affiliated Hospital of Zhengzhou University
The First Affiliated Hospital of Zhengzhou University collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Nanfang Hospital of Southern Medical University
Nanfang Hospital of Southern Medical University collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Guizhou Provincial People's Hospital
Guizhou Provincial People's Hospital collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Henan Cancer Hospital
Henan Cancer Hospital collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Yunnan Cancer Hospital
Yunnan Cancer Hospital collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Guangdong Provincial People's Hospital
Guangdong Provincial People's Hospital collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Guangzhou Medical University
Affiliated Cancer Hospital and Institute of Guangzhou Medical University collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Fujian Medical University Union Hospital
Fujian Medical University Union Hospital collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Shanxi Province Cancer Hospital
Shanxi Province Cancer Hospital collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Sun Yat-sen University
Sun Yat-sen University collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
|
Scientific Institute San Raffaele
Scientific Institute San Raffaele collects clinical information, preoperative CT images, and the golden standard for peritoneal metastasis status for each patient.
Clinical information includes gender, age, gastric disease background, tumor markers, gastric cancer stage, gastric cancer type, treatment program, smoking history, alcohol history, etc.
All patients undergo diagnostic laparoscopy.
Any suspicious lesion discovered during laparoscopy is biopsied and pathologically examined to determine peritoneal metastasis status.
|
Each participant with gastric cancer will undergo enhanced CT examination for detection of peritoneal metastasis.
Within two weeks of CT examination, the participant will undergo diagnostic laparoscopy to confirm the status of peritoneal metastasis.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The aera under the receiver operating characteristic curve (AUC) of intelligent analysis system
Time Frame: three months
|
AUC of the intelligent analysis system in predicting peritoneal metastasis for gastric cancer.
|
three months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The accuray of intelligent analysis system in predicting peritoneal metastasis
Time Frame: three months
|
The agreement between the prediction outcome of intelligent analysis system and the golden standard of peritoneal metastasis.
|
three months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The statistical significance of intelligent analysis system in risk stratification
Time Frame: Three years
|
Statistical significance (P value) of progression-free survival (PFS) in gastric cancer patients between high-risk and low-risk group identified by the intelligent analysis system.
|
Three years
|
|
Progression-free survival time
Time Frame: Three years
|
The progression-free survival time in patient subgroups stratified by the intelligent analysis system.
|
Three years
|
|
Overall survival
Time Frame: Three years
|
The overall survival time in patient subgroups stratified by the intelligent analysis system.
|
Three years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
General Publications
- Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016 Sep;27(suppl 5):v38-v49. doi: 10.1093/annonc/mdw350. No abstract available.
- Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Feb;20(2):167-192. doi: 10.6004/jnccn.2022.0008.
- Hur H, Lee HH, Jung H, Song KY, Jeon HM, Park CH. Predicting factors of unexpected peritoneal seeding in locally advanced gastric cancer: indications for staging laparoscopy. J Surg Oncol. 2010 Dec 1;102(7):753-7. doi: 10.1002/jso.21685.
- Burbidge S, Mahady K, Naik K. The role of CT and staging laparoscopy in the staging of gastric cancer. Clin Radiol. 2013 Mar;68(3):251-5. doi: 10.1016/j.crad.2012.07.015. Epub 2012 Sep 14.
- Dong D, Tang L, Li ZY, Fang MJ, Gao JB, Shan XH, Ying XJ, Sun YS, Fu J, Wang XX, Li LM, Li ZH, Zhang DF, Zhang Y, Li ZM, Shan F, Bu ZD, Tian J, Ji JF. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol. 2019 Mar 1;30(3):431-438. doi: 10.1093/annonc/mdz001.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CASMI003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.